domains / families / science / mpn-progression-monitor-agent

mpn-progression-monitor-agent

separate

AI-powered myeloproliferative neoplasm monitoring for disease progression prediction, treatment response tracking, and transformation risk assessment in PV, ET, and myelofibrosis.

When to use

• When monitoring JAK2/CALR/MPL mutation burden over time.
• For predicting fibrosis progression in PV/ET.
• To assess risk of blast transformation.
• When tracking treatment response to JAK inhibitors.
• For calculating dynamic risk scores (DIPSS, MIPSS70).

Skill page

Source